Andrew Hyland, PhD
Andrew Hyland, PhD is the Chair of the Department of Health Behavior at Roswell Park Cancer Institute. Dr. Hyland holds a PhD in Epidemiology and a MA in Statistics from the University at Buffalo.
Dr. Hyland’s primary research interests lie in evaluating the impact of policies aimed at reducing the morbidity and mortality associated with the use of tobacco products.
He has over 200 peer reviewed publications, is the principal investigator on numerous grants and contracts, and is the Deputy Editor for the journal Tobacco Control. Dr. Hyland is the scientific leader of the Population Assessment of Tobacco and Health study, which is supported by the National Institute on Drug Abuse and the Food and Drug Administration to study nearly 60,000 adults and children to understand the impact of regulations to reduce the disease burden caused by tobacco products.
Examples of his work include evaluations of the economic impact of clean indoor air laws, creating methods to estimate levels of secondhand smoke exposure in the workplace and the home, developing methods to track contraband tobacco products and their impact on smoking cessation, and assessing the impact of a variety of tobacco policy measures on tobacco use behavior the population.